Feng Ren

机构：Insilicos (United States), Insilicogen (South Korea), Henan Medical University · ORCID：0000-0001-9157-9182

发表论文 109 篇 · 总被引 3082 次 · h-index 28

代表论文

• A generative AI-discovered TNIK inhibitor for idiopathic pulmonary fibrosis: a randomized phase 2a trial (2025 · Nature Medicine · 被引 116)
• Quantum-computing-enhanced algorithm unveils potential KRAS inhibitors (2025 · Nature Biotechnology · 被引 69)
• A novel, covalent broad-spectrum inhibitor targeting human coronavirus Mpro (2025 · Nature Communications · 被引 35)
• Oral ENPP1 inhibitor designed using generative AI as next generation STING modulator for solid tumors (2025 · Nature Communications · 被引 33)
• Discovery of a bifunctional PKMYT1-targeting PROTAC empowered by AI-generation (2025 · Nature Communications · 被引 18)
• Discovery of Pyrrolopyrazine Carboxamide Derivatives as Potent and Selective FGFR2/3 Inhibitors that Overcome Mutant Resistance (2025 · Journal of Medicinal Chemistry · 被引 15)